Largest pharmaceuticals by total debt
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
AbbVie leads the 35 pharmaceuticals ranked by total debt, at SEK 685.6B, ahead of Pfizer (SEK 658.2B) and Merck & Co (SEK 500.8B). Figures as of 18 Nov 2026, 14:39 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 35
- First
- AbbVieSEK 685.6B
- Median
- SEK 53.6B
- Combined market value
- SEK 52.26T
- Countries
- 10
- Not ranked
- 26no total debt on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total debt ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | SEK 685.6B | SEK 5.24T | SEK 2,962.26 | 0.42% down | 26% up | ||
| 2 | PfizerPFE · Health Care | SEK 658.2B | SEK 1.65T | SEK 289.14 | 0.02% up | 14% up | ||
| 3 | Merck & CoMRK · Health Care | SEK 500.8B | SEK 3.52T | SEK 1,428.26 | 1.95% down | 51% up | ||
| 4 | Johnson & JohnsonJNJ · Health Care | SEK 486.9B | SEK 6.81T | SEK 2,827.67 | 0.16% down | 38% up | ||
| 5 | Bristol-Myers SquibbBMY · Health Care | SEK 458.2B | SEK 1.27T | SEK 618.90 | 0.73% down | 34% up | ||
| 6 | Eli LillyLLY · Health Care | SEK 431.7B | SEK 12.82T | SEK 14,391.49 | 0.10% up | 35% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | SEK 310.6B | SEK 698.5B | SEK 218.64 | 0.55% down | 54% up | ||
| 8 | AstraZenecaAZN · Health Care | SEK 300.9B | SEK 2.85T | SEK 1,837.26 | 0.74% down | 2% up | ||
| 9 | NovartisNVS · Health Care | SEK 291.8B | SEK 3.02T | SEK 1,600.43 | 1.01% down | 25% up | ||
| 10 | SanofiSNY · Health Care | SEK 210.8B | SEK 1.16T | SEK 482.99 | 0.04% up | 4% down | ||
| 11 | Novo NordiskNVO · Health Care | SEK 197.4B | SEK 1.81T | SEK 409.91 | 0.86% down | 17% down | ||
| 12 | GSKGSK · Health Care | SEK 194.9B | SEK 1T | SEK 499.96 | 0.01% down | 6% up | ||
| 13 | ViatrisVTRS · Health Care | SEK 146.4B | SEK 239.8B | SEK 209.20 | 0.71% up | 96% up | ||
| 14 | Abbott LaboratoriesABT · Health Care | SEK 131.3B | SEK 1.84T | SEK 1,063.55 | 0.05% down | 17% down | ||
| 15 | ZoetisZTS · Health Care | SEK 91.8B | SEK 347B | SEK 853.95 | 0.71% up | 29% down | ||
| 16 | Royalty PharmaRPRX · Health Care | SEK 90.9B | SEK 402.1B | SEK 699.25 | 0.23% up | 78% up | ||
| 17 | Jazz PharmaceuticalsJAZZ · Health Care | SEK 54.4B | SEK 156.7B | SEK 2,440.72 | 0.18% down | 37% up | ||
| 18 | GenmabGMAB · Health Care | SEK 53.6B | SEK 325.2B | SEK 527.48 | 0.06% down | 70% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | SEK 40.8B | SEK 134.1B | SEK 268.26 | 2.17% up | 20% up | ||
| 20 | Amneal PharmaceuticalsAMRX · Health Care | SEK 26.1B | SEK 75.8B | SEK 217.44 | 1.36% up | 83% up | ||
| 21 | BridgeBio PharmaBBIO · Health Care | SEK 20.4B | SEK 152.4B | SEK 782.34 | 0.29% up | 17% up | ||
| 22 | Regeneron PharmaceuticalsREGN · Health Care | SEK 20.2B | SEK 1.01T | SEK 9,800.76 | 0.74% up | 36% up | ||
| 23 | Ionis PharmaceuticalsIONS · Health Care | SEK 18.4B | SEK 46.5B | SEK 279.33 | 2.00% up | 64% down | ||
| 24 | BeOne MedicinesONC · Health Care | SEK 10.4B | SEK 475.3B | SEK 4,161.16 | 0.87% down | 17% up | ||
| 25 | Ascendis PharmaASND · Health Care | SEK 8.1B | SEK 180.6B | SEK 2,753.12 | 0.06% down | 28% up | ||
| 26 | InsmedINSM · Health Care | SEK 5.6B | SEK 272B | SEK 1,240.04 | 0.18% up | 40% down | ||
| 27 | Madrigal PharmaceuticalsMDGL · Health Care | SEK 3.5B | SEK 99.2B | SEK 4,271.07 | 0.36% down | 24% down | ||
| 28 | Legend BiotechLEGN · Health Care | SEK 3.2B | SEK 33.1B | SEK 170.55 | 4.22% up | 42% down | ||
| 29 | CytokineticsCYTK · Health Care | SEK 2.9B | SEK 73.7B | SEK 528.75 | 0.78% up | 20% down | ||
| 30 | TG TherapeuticsTGTX · Health Care | SEK 2.5B | SEK 97.5B | SEK 644.74 | 1.22% up | 107% up | ||
| 31 | Cogent BiosciencesCOGT · Health Care | SEK 2.3B | SEK 50B | SEK 287.36 | 1.58% up | 20% down | ||
| 32 | Dr. Reddy's LaboratoriesRDY · Health Care | SEK 2B | SEK 126.5B | SEK 151.75 | 0.95% up | 5% up | ||
| 33 | Axsome TherapeuticsAXSM · Health Care | SEK 1.9B | SEK 73B | SEK 1,387.73 | 0.49% up | 7% down | ||
| 34 | Rhythm PharmaceuticalsRYTM · Health Care | SEK 1.1B | SEK 81.6B | SEK 1,177.37 | 0.60% down | 13% up | ||
| 35 | Definium TherapeuticsDFTX · Health Care | SEK 412.2M | SEK 41B | SEK 299.34 | 0.31% up | 169% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1576 SEK). 26 companies have no total debt on file and are not ranked here.
Questions and answers
Which pharmaceuticals rank first by total debt?
AbbVie (SEK 685.6B), Pfizer (SEK 658.2B) and Merck & Co (SEK 500.8B) are the top three of the 35 pharmaceuticals ranked by total debt as of 18 Nov 2026, 14:39 UTC.
How many pharmaceuticals are in this ranking?
35 are ranked by total debt. 26 more have no total debt on file and are left out rather than ranked at zero.
What are these pharmaceuticals worth together?
The 35 pharmaceuticals ranked by total debt have a combined market value of SEK 52.26T as of 18 Nov 2026, 14:39 UTC.
What does ranking by total debt measure?
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-debt
Underlying data: Yahoo Finance; SEC EDGAR.